newsfilter
← Latest News
PR Newswire·

UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics

UTime Limited (NASDAQ: WTO) ("UTime" or the "Company"), which continues to build on its strengths in the global healthcare sector, has announced that ...